FTH1 and head and neck carcinoma: In myeloid leukemia (Zhang et al., 2023), hepatocellular carcinoma, Hodgkin’s lymphoma, head and neck carcinoma (Liao et al., 2023), and pancreatic cancer, FTH1 has been shown to act as an oncogene.